Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-1-24
pubmed:abstractText
We have developed a therapeutic for the treatment of anthrax using an affinity-enhanced monoclonal antibody (ETI-204) to protective antigen (PA), which is the central cell-binding component of the anthrax exotoxins. ETI-204 administered preexposure by a single intravenous injection of a dose of between 2.5 and 10 mg per animal significantly protected rabbits from a lethal aerosolized anthrax spore challenge ( approximately 60 to 450 times the 50% lethal dose of Bacillus anthracis Ames). Against a similar challenge, ETI-204 administered intramuscularly at a 20-mg dose per animal completely protected rabbits from death (100% survival). In the postexposure setting, intravenous administration of ETI-204 provided protection 24 h (8 of 10) and 36 h (5 of 10) after spore challenge. Administration at 48 h postchallenge, when 3 of 10 animals had already succumbed to anthrax infection, resulted in the survival of 3 of 7 animals (43%) for the duration of the study (28 days). Importantly, surviving ETI-204-treated animals were free of bacteremia by day 10 and remained so until the end of the studies. Only 11 of 51 ETI-204-treated rabbits had positive lung cultures at the end of the studies. Also, rabbits that were protected from inhalational anthrax by administration of ETI-204 developed significant titers of PA-specific antibodies. Presently, the sole therapeutic regimen available to treat infection by inhalation of B. anthracis spores is a 60-day course of antibiotics that is effective only if administered prior to or shortly after exposure. Based upon results reported here, ETI-204 is an effective therapy for prevention and treatment of inhalational anthrax.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10085027, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10328075, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-10477781, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11292703, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11312020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11390699, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11483266, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11535328, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11544370, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11700562, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11796581, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-11997437, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12042864, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12396909, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12435060, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12468536, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-12700348, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-1438214, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-14670324, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-15044490, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-1909998, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-2111283, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-2470825, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3148815, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3384478, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3711080, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-3917427, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-6285339, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-7086666, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-7783638, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8051159, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8380282, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-8486963, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9039918, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9393812, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9563949, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9632621, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9682372, http://linkedlifedata.com/resource/pubmed/commentcorrection/15664918-9822127
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
795-802
pubmed:dateRevised
2010-9-20
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
pubmed:affiliation
Elusys Therapeutics Inc., P.O. Box 102, 25 Riverside Drive, Pine Brook, NJ 07058, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't